Skip to Main Content

Paper Details

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
PLoS One
20
2016
-, -NCOA4 fusion, CRPC, CRPCs, MSMB, MSMB protein, Microseminoprotein-Beta, Microseminoprotein-beta, NCOA4, PC, PSA, Prostate Cancer, androgen, benign prostatic hyperplasia, cancerous, cancerous cells, castration-resistant PC, mRNA, nuclear receptor co-activator 4, patients, prostate cancer, read, rs10993994, single nucleotide polymorphism
Author NameAffiliation
Matti AnnalaProstate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere
Matti NykterProstate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere
George Steven BovaProstate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere
Johanna SchleutkerProstate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere
Johanna SchleutkerProstate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere
Tapio VisakorpiProstate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere
Tapio VisakorpiTampere University Hospital
  • 1 - 7

Datasets

Release 1.2